首页 | 本学科首页   官方微博 | 高级检索  
检索        

生长抑素受体介导的靶向放疗在消化系统肿瘤治疗中的研究进展
引用本文:郭宏华,张建忠,王江滨.生长抑素受体介导的靶向放疗在消化系统肿瘤治疗中的研究进展[J].国外医学:内科学分册,2007,34(8):475-478.
作者姓名:郭宏华  张建忠  王江滨
作者单位:吉林大学中日联谊医院消化内科,吉林长春130031
摘    要:生长抑素受体介导靶向放疗是建立在对生长抑素、生长抑素类似物及其受体的研究基础之上.目前已经证实生长抑素类似物有良好的抗肿瘤效应,应用放射性核素标记生长抑素类似物与消化系统肿瘤高表达的生长抑素受体特异性和选择性结合以达到两者共同抗肿瘤作用的方法,具有重要的应用前景.本文就生长抑素受体介导的靶向放疗在消化系统肿瘤治疗方面的研究进展作一综述.

关 键 词:靶向放疗  生长抑素类似物  生长抑素受体  放射性核素
文章编号:1004-2369(2007)08-0475-04
修稿时间:2006-12-12

Progress in researches on somatostatin receptor mediated targeted radiotherapy in treatment for digestive system tumor
GUO Hong-hua,ZHANG Jian-zhong,WANG Jiang-bin.Progress in researches on somatostatin receptor mediated targeted radiotherapy in treatment for digestive system tumor[J].Foreign Medical Sciences(Section of Internal Medicine),2007,34(8):475-478.
Authors:GUO Hong-hua  ZHANG Jian-zhong  WANG Jiang-bin
Institution:Department of Gastroenterology, China-Japan Union Hospital, Jilin University, Changchun 130031, China
Abstract:Somatostatin receptor(SSTR)mediated targeted radiotherapy is established based on researches on somatostatin analog(SSTA)and SSTR.At present it has been confirmed that SSTA is an effective anti-carcinoma.The SSTA marked by radioactive nuclide combines with SSTR which is highly expressed in digestive system tumor specially or selectively,will realize the anti-carcinoma effect of SSTA.It is supposed to have a promising application prospective.This article summarized the progress in researches on SSTR mediated radiotherapy in treatment for digestive system tumor.
Keywords:Targeted radiotherapy  Somatostatin analog  Somatostatin receptor  Radionuclide
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号